Exciva raised €51M in a Series B round announced on January 20, 2026. German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
Exciva, based in Heidelberg, Germany, announced €51M in Series B financing on January 20, 2026.
Participants include EQT Life Sciences, Modi Ventures, Gimv, LifeArc Ventures, Andera Partners, Fountain Healthcare Partners, Carma Fund, LBBW VC.
Oviva provides personalized dietary advice combined with digital tools to help individuals change their habits and improve their health.
German deeptech firm Orbem is using AI-powered MRI technology to scan biological samples in food, construction and medical environments.
Orbital develops AI technology tailored to the specific requirements of real estate legal work, an area that has seen relatively limited coverage from broader legal technology platforms.